﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>2</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2016</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Introduction to chemical construction of immunotoxins and their applications in the treatment of diseases</ArticleTitle>
    <FirstPage>e02</FirstPage>
    <LastPage>
    </LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Seyed Seifollah</FirstName>
        <LastName>Beladi-Mousavi</LastName>
      </Author>
      <Author>
        <FirstName>Khadije</FirstName>
        <LastName>Hajibabaei</LastName>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Hamledari</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad-Reza</FirstName>
        <LastName>Tamadon</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad-Reza</FirstName>
        <LastName>Ardalan</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>11</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <Abstract>Immunotoxins are mostly contain a monoclonal antibody part linked to a toxin, generally of bacterial or plant origin. The antibody gives specificity (ability to identify and react with the target), while the toxin gives cytotoxicity (ability to kill the target). In this paper, we will explain about the different parts of immunotoxins, linkage methods of the antibody to the toxin and their application in treatment of cancer and other diseases. This review will help physicians better inform patients about the potential benefits of these experimental treatments.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Immunotoxins</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Monoclonal antibody</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Toxin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chemical cross linkers</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cancer</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>